HHS Analysis Supports Medicare Payment Cut, Citing Drug Overuse Concerns
What happened
Economists at the Department of Health and Human Services produced an internal agency analysis arguing that the federal drug discount program, the 340B Program, may incentivize hospitals to overuse expensive drugs and expand through consolidation. The analysis, which was authored by Casey B. Mulligan, supports a Medicare payment cut that the administration has proposed. Hospital groups have strongly opposed this proposed cut.
From medicaldaily.com
Why it matters
The 340B Program requires drugmakers to sell outpatient drugs at reduced prices to qualifying hospitals serving low-income patients. Hospitals buy these drugs at a discounted rate but are paid by Medicare at a standard rate, allowing them to keep the difference. The proposed payment cut directly affects this financial spread, which is a key revenue source for these institutions.
From medicaldaily.com
Who's involved
- Casey B. MulliganAuthor of the internal agency analysis tracking Medicare drug payments
- Health Resources and Services AdministrationUnited States government agency whose policies manage drug pricing and the 340B rebate program
- MedicareUS federal health insurance program whose payment structure is being debated
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- American Hospital AssociationSpeculative
Hospital industry trade groups might see reduced revenue due to the proposed Medicare payment cut.
- Eli Lilly and CompanySpeculative
Eli Lilly and Company might be affected by market price changes related to hospital incentives to overuse high-cost drugs.
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.- Medicare payment cut may change drug pricing for Eli LillyEli Lilly and Company may face changes in revenue due to proposed Medicare drug payment cutsPossible
- Proposed Medicare payment cut may threaten AHA member hospitals' revenueThe proposed Medicare payment cut threatens the revenue and operational viability of the American Hospital Association's members.Possible
- Medicare drug payment cut proposal puts pressure on CongressCongress may need to address the proposed Medicare drug payment cutPossible
Keep exploring
The entities involved
-
Health Resources and Services Administration
United States government agency
-
Medicare
US federal health insurance
Related events
- BrightSpring Health Services serves patients through Medicare and operates in the US market.
- HHS threatened to withhold Medicare funding.
- Backing legislation to strengthen Medicare payments.
- Health Care Service Corporation offers Medicare and supplemental policies.
- The U.S. federal government manages the Medicare program.